Concertapp, Inc. – Trademark Portfolio

Entity Type: 03

Concertapp, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CHORDIO. The owner is based in Issaquah, WA.

1017 Pine Crest Cir NE

Issaquah, WA 98029

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CHORDIO
CHORDIO
Registered 2022
CHORDIO
CHORDIO
Registered 2022

Trademark Classifications

Concertapp, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Concertapp, Inc. have?

Concertapp, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Concertapp, Inc. file in?

Concertapp, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Concertapp, Inc.'s most well-known trademarks?

Concertapp, Inc.'s registered trademark portfolio includes well-known marks such as CHORDIO. These are among 2 currently registered trademarks in the portfolio.

What is Concertapp, Inc.'s trademark registration success rate?

Concertapp, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.